Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Inclusion Criteria

• •Male or female subjects, 18 years or older.
• •Subjects diagnosed with either POAG or OHT in both eyes. The diagnosis of POAG must include evidence of:
• •1. Optic disc or retinal nerve fiber layer structural abnormalities (substantiated by OCT); and/or
• •2. Visual field abnormality (substantiated with the Humphrey automated perimeter using the SITA Standard 24-2 testing algorithm. Mean deviation (MD) score must be -15dB \< MD \< 0dB.
• •Subjects with a 9:00AM (+/- 1 hour) median IOP in both eyes that is:
• •1. Greater than or equal to 18mmHg at the Screening Visit or have documented history of IOP being greater than or equal to 22mmHg;
• •2. Greater than or equal to 22mmHg at both Eligibility Visits.
• •Subjects currently using one or more topical medications to control their IOP.
• •Subjects able and willing to comply with the protocol, including randomization assignment and all follow-up visits.
• •Subjects that sign the informed consent form.